Previous reports have shown that OXT is able to attenuate or reverse the phencyclidine- and MK801-impairing effects on SI and PPI in rats and zebrafish (e.g., [26,27,54]), as well as PCP-induced hyperactivity in rats [24]. Here, OXT is linked to pneumocystosis.